Stirland Lucy E, Choate Radmila, Zanwar Preeti Pushpalata, Zhang Panpan, Watermeyer Tamlyn J, Valletta Martina, Torso Mario, Tamburin Stefano, Saeed Usman, Ridgway Gerard R, Moukaled Shirine, Lusk Jay B, Loi Samantha M, Littlejohns Thomas J, Kuźma Elżbieta, James Sarah-Naomi, Grande Giulia, Foote Isabelle F, Cousins Katheryn A Q, Butler Joe, AbuHamdia Abrar, Avelino-Silva Thiago J, Suryadevara Vidyani
Division of Psychiatry, Institute of Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, UK.
Global Brain Health Institute, University of California San Francisco Memory and Aging Center, San Francisco, California, USA.
Alzheimers Dement. 2025 Aug;21(8):e70546. doi: 10.1002/alz.70546.
Multimorbidity-the co-occurrence of two or more chronic health conditions-affects > 86% of people with dementia. It is associated with cognitive and functional decline, reduced health-related quality of life, increased health-care use, and higher mortality. The relationship between multimorbidity and dementia is potentially bidirectional; conditions such as hypertension and diabetes increase the risk of developing dementia, and cognitive impairment can complicate their management. This complexity presents challenges in health care and research, affecting treatment decisions and often leading to the exclusion of these individuals from clinical trials. Understanding multimorbidity through long-term prospective studies is crucial to clarify its relationship with dementia. Investigating specific disease combinations, environmental and genetic factors, and their impacts on cognitive health will guide the development of effective prediction models and inclusive intervention strategies for diverse global populations across the life course. HIGHLIGHTS: Multimorbidity affects > 86% of individuals with dementia, worsening outcomes. The relationship between multimorbidity and dementia is potentially bidirectional. Chronic conditions hinder dementia management and clinical trial inclusion. Life-course multimorbidity research is key to dementia risk reduction strategies. Prospective studies are needed to improve prediction models and interventions.
多重疾病(即两种或更多慢性健康状况同时出现)影响着超过86%的痴呆症患者。它与认知和功能衰退、健康相关生活质量下降、医疗保健使用增加以及更高的死亡率相关。多重疾病与痴呆症之间的关系可能是双向的;高血压和糖尿病等疾病会增加患痴呆症的风险,而认知障碍会使其管理变得复杂。这种复杂性给医疗保健和研究带来了挑战,影响治疗决策,并且常常导致这些个体被排除在临床试验之外。通过长期前瞻性研究来了解多重疾病对于阐明其与痴呆症的关系至关重要。研究特定的疾病组合、环境和遗传因素及其对认知健康的影响,将指导为全球不同人群在整个生命过程中开发有效的预测模型和包容性干预策略。要点:多重疾病影响超过86%的痴呆症患者,使病情恶化。多重疾病与痴呆症之间的关系可能是双向的。慢性病阻碍痴呆症管理和临床试验纳入。生命历程多重疾病研究是降低痴呆症风险策略的关键。需要进行前瞻性研究以改进预测模型和干预措施。